Fulgent Genetics
FLGT
21 hedge funds and large institutions have $11.4M invested in Fulgent Genetics in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.
3.35% less ownership
Funds ownership: 16.83% → 13.48% (-3.3%)
5% less funds holding
Funds holding: 22 → 21 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
40% less capital invested
Capital invested by funds: $19M → $11.4M (-$7.64M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$812K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$449K |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
+$353K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$97.2K |
| 5 |
JP Morgan Chase
New York
|
+$22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.79M |
| 2 |
SC
Scholtz & Company
Stamford,
Connecticut
|
-$367K |
| 3 |
ECM
Element Capital Management
New York
|
-$135K |
| 4 |
Millennium Management
New York
|
-$93K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$64K |
FLGT Hedge Fund Activity: Q3 2017 in Review
21 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q3 2017, worth a combined $11.4M — down 40% from $19M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of FLGT and 4 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 5 added.
The largest buyer was Granahan Investment Management, adding an estimated $812K. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $4.79M sold.
- 21 institutional investors held Fulgent Genetics (FLGT) as of Q3 2017, down from 22 in Q2 2017.
- Funds reported $11.4M of Fulgent Genetics stock for Q3 2017, down 40% quarter-over-quarter.
- 4 funds opened new Fulgent Genetics positions in Q3 2017 and 5 closed out, a net change of -1 holder.
- The largest Fulgent Genetics buyer in Q3 2017 was Granahan Investment Management, an estimated $812K added.
- The largest Fulgent Genetics seller in Q3 2017 was Cormorant Asset Management, an estimated $4.79M sold.
Based on aggregated 13F filings for Q3 2017.